Senna
Brand names: Senokot, Manevac
Senna is a stimulant laxative used in obstetric and gynaecological care for constipation, including pregnancy-related and opioid-induced constipation when bulk-forming measures are insufficient.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Its anthraquinone glycosides are activated by colonic bacteria to stimulate the myenteric plexus, increasing colonic motility and reducing water absorption to promote a bowel movement.
Prescribing in practice
- It should be avoided where intestinal obstruction is suspected, and prolonged use is discouraged; it may be used in pregnancy when dietary measures and a bulk-forming laxative have not worked.
- It can cause abdominal cramping and, with overuse, electrolyte disturbance such as hypokalaemia.
- For opioid-induced constipation, a stimulant laxative such as senna is a rational choice, sometimes combined with a stool softener.
Monitoring
Monitoring is clinical, reviewing bowel response and avoiding prolonged unsupervised use that risks electrolyte imbalance.
Counselling the patient
- It usually works overnight, so it is often taken at bedtime.
- Increase fluid and fibre intake alongside the laxative where possible.
- Stop and seek advice if you have severe abdominal pain or no bowel movement despite treatment.
Evidence & guidelines
Stimulant laxatives such as senna are recommended by NICE for short-term and opioid-related constipation when first-line measures fail.
Reference: NICE CG190; RCOG obstetric pharmacology guidance; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.